SCHEMBL4608213

SCHEMBL4608213

CCCCCCCCCCCCCC=CC(O)C(N)COCCCCCC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.65
KMT2A Q03164 4/20 0.65
CETP P11597 4/20 0.65
SPHK2 Q9NRA0 4/20 0.65
SPHK1 Q9NYA1 4/20 0.65
MAPT P10636 3/20 0.65
GMNN O75496 2/20 0.65
LMNA P02545 2/20 0.65
GLA P06280 2/20 0.65
POLB P06746 2/20 0.65
THRB P10828 2/20 0.65
MAPK1 P28482 2/20 0.65
CXCR5 P32302 2/20 0.65
CCR6 P51684 2/20 0.65
BLM P54132 2/20 0.65
UBE2N P61088 2/20 0.65
CYP2D6 P10635 2/20 0.65
ALDH1A1 P00352 2/20 0.65
TP53 P04637 1/20 0.65
CYP1A2 P05177 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27491463 1.00 MEN1 (0.65) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL27705510 1.00 MEN1 (0.65) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL9112746 1.00 MEN1 (0.65) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL28772557 1.00 MEN1 (0.65) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL5616499 1.00 MEN1 (0.65) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL312332 1.00 MEN1 (0.65) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL9011612 0.98 MEN1 (0.63) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL9513991 0.94 S1PR1 (0.59) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL8531537 0.94 S1PR1 (0.59) MEN1KMT2ACETPSPHK2SPHK1
SCHEMBL13009766 0.89 SPHK2 (0.67) MEN1KMT2ACETPSPHK2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3386991-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE Janssen Pharmaceutica NV (BE) 2018-10-17 EP claimed
WO-2017100662-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE JANSSEN PHARMACEUTICA NV (BE) 2017-06-15 WO claimed
EP-3386991-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE Janssen Pharmaceutica NV (BE) 2018-10-17 EP disclosed
WO-2017100662-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE JANSSEN PHARMACEUTICA NV (BE) 2017-06-15 WO disclosed
EP-1349536-B1 STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM UNILEVER PLC (GB) 2008-07-23 EP disclosed
US-6949247-B2 Stable skin care compositions containing a retinoid and a retinoid booster system UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2005-09-27 US disclosed
EP-1345586-B1 STABLE SKIN CARE PRODUCT CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM IN A DUAL COMPARTMENT PACKAGE UNILEVER PLC (GB) 2005-03-09 EP disclosed
EP-0742789-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND LIPOSOMES, AND METHODS OF USE THEROF LIPOSOME CO INC (US) 2000-08-30 EP disclosed
EP-1008342-A2 Pharmaceutically active compounds and liposomes, and methods of use thereof THE LIPOSOME COMPANY, INC. (US) 2000-06-14 EP disclosed
US-5681589-A ANTICANCER AGENTS THE LIPSOME COMPANY, INC. (US) 1997-10-28 US disclosed
US-5677337-A ADMINSTERING AS ANTICARCINOGENIC AGENTS THE LIPOSOME COMPANY, INC. (US) 1997-10-14 US disclosed
US-5631394-A Pharmaceutically active ceramide-related compounds THE LIPOSOME COMPANY, INC. (US) 1997-05-20 US disclosed
EP-0742789-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND LIPOSOMES, AND METHODS OF USE THEROF THE LIPOSOME COMPANY, INC. (US) 1996-11-20 EP disclosed
WO-1995021175-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND LIPOSOMES, AND METHODS OF USE THEROF THE LIPOSOME COMPANY, INC. (US) 1995-08-10 WO disclosed